" This is an email reply from Gerald to me on that subject a while back. : "While we canceled the deal with Generex, we maintain the option." http://markets.financialcontent.com/stocks/news/read/18673668/Generex_Biotechnology_and_Amarantus_BioSciences_Announce_Oral On Fri, Aug 30, 2013 at 6:07 PM, Gerald Commissiong <gerald@amarantus.com> wrote: All will be revealed in time Gerald E. Commissiong President & CEO